DNOW:NYSEDNOW Inc. Analysis
Data as of 2026-03-29 - not real-time
$12.25
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
DNOW is trading below its longer‑term moving averages, signaling a bearish technical backdrop, yet the short‑term momentum indicator has turned bullish and the price sits just above a well‑defined support level. The relative strength index hovers near the neutral zone, suggesting limited downside pressure while volatility remains elevated, reflecting a history of sharp drawdowns. On the fundamentals side, the company posted a striking surge in revenue and an expanding adjusted EBITDA in the latest quarter, driven by the integration of a recent merger that broadened its market footprint and reduced cyclical exposure. However, earnings per share remain negative, free cash flow is in the red, and leverage is elevated, raising concerns about cash generation and debt sustainability. Valuation metrics show a forward price‑to‑earnings multiple far beneath the industry average and a discounted cash‑flow model that points to a material upside potential relative to the current market price. Analyst sentiment is strongly positive, with a consensus recommendation of strong buy, though a pending securities class‑action investigation introduces a legal risk element.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD histogram despite overall bearish trend
- Price positioned just above key support with upside to fair‑value estimate
- Recent revenue surge and merger synergies boosting top‑line momentum
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward earnings multiple markedly below peer average
- Analyst consensus of strong buy and target price above current levels
- Diversified end‑market exposure reducing cyclical risk after merger
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Discounted cash‑flow model indicating substantial upside potential
- Strategic positioning in industrial distribution with growing demand for MRO solutions
- Long‑term value creation from integrated supply chain and service offerings
Key Metrics & Analysis
Financial Health
Revenue Growth68.00%
Profit Margin-3.16%
P/E Ratio11.7
ROE-5.23%
ROA2.68%
Debt/Equity27.43
P/B Ratio1.0
Op. Cash Flow$155.0M
Free Cash Flow$-709625024
Industry P/E28.1
Technical Analysis
TrendBearish
RSI48.5
Support$10.94
Resistance$12.50
MA 20$11.78
MA 50$13.60
MA 200$14.32
MACDBullish
VolumeStable
Fear & Greed Index65.98
Valuation
Fair Value$18.78
Target Price$16.00
Upside/Downside30.61%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.99
Volatility75.68%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.